Go Pro

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health logo
$238.79 +1.07 (+0.45%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$238.73 -0.06 (-0.02%)
As of 07/2/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
3
Buy
15

Based on 18 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 3 have given a hold rating, and 15 have given a buy rating for CAH.

Consensus Price Target

$247.80
3.77% Upside
According to the 18 analysts' twelve-month price targets for Cardinal Health, the average price target is $247.80. The highest price target for CAH is $275.00, while the lowest price target for CAH is $208.00. The average price target represents a forecasted upside of 3.77% from the current price of $238.79.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAH Analyst Ratings Over Time

TypeCurrent Forecast
7/3/25 to 7/3/26
1 Month Ago
6/3/25 to 6/3/26
3 Months Ago
4/4/25 to 4/4/26
1 Year Ago
7/3/24 to 7/3/25
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
11 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$247.80$241.80$245.67$157.43
Forecasted Upside3.77% Upside23.26% Upside14.80% Upside-4.47% Downside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cardinal Health Stock vs. The Competition

TypeCardinal HealthMedical CompaniesBroader Market
Consensus Rating Score
2.83
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside3.77% Upside712.94% Upside13.31% Upside
News Sentiment Rating
Positive News

See Recent CAH News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
7/2/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Daniel Grosslight
Daniel Grosslight
1 of 5 stars
Reiterated RatingBuy
7/2/2026
Bank of America Corporation logo
Bank of America
4 of 5 stars
Allen Lutz
Allen Lutz
Not Rated
Boost TargetBuy$240.00 ➝ $260.00+8.08%
6/12/2026 DowngradeStrong-BuyHold
5/19/2026 DowngradeBuy (B+)Buy (B)
5/4/2026Lower TargetNeutral$243.00 ➝ $215.00+9.16%
5/1/2026Boost TargetBuy$251.00 ➝ $255.00+31.40%
5/1/2026 Set Target$248.00+27.79%
5/1/2026Lower TargetOverweight$256.00 ➝ $245.00+25.57%
4/28/2026Initiated CoverageOutperform
4/28/2026 Boost TargetOverweight$245.00 ➝ $255.00+25.90%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
4/8/2026Lower TargetOutperform$260.00 ➝ $240.00+11.48%
3/9/2026Reiterated RatingOutperform$275.00+23.70%
2/24/2026Boost TargetOverweight$243.00 ➝ $258.00+14.75%
2/11/2026 Boost TargetBuy$232.00 ➝ $248.00+12.31%
2/6/2026Set TargetBuy$260.00+14.00%
2/6/2026Boost TargetOutperform$222.00 ➝ $235.00+3.17%
1/22/2026Boost TargetBuy$220.00 ➝ $270.00+29.34%
11/18/2025 Boost TargetHold$195.00 ➝ $208.00+0.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:57 AM ET.


Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 1, 2026. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • The company recently reported earnings per share (EPS) of $3.17, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
  • Cardinal Health, Inc. has a consensus rating of "Moderate Buy" from analysts, suggesting positive sentiment and confidence in the company's future performance.
  • The current stock price is around $246.93, which reflects a favorable valuation compared to its projected earnings growth.
  • Cardinal Health, Inc. has increased its quarterly dividend to $0.5158, demonstrating a commitment to returning value to shareholders and indicating financial stability.
  • The company has shown a year-over-year revenue increase of 11.0%, highlighting its ability to grow and adapt in the competitive healthcare market.

Cardinal Health
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • The company has a negative return on equity of 92.61%, which may raise concerns about its efficiency in generating profits from shareholders' equity.
  • Despite revenue growth, Cardinal Health, Inc. reported a net margin of only 0.62%, indicating that profitability may be a challenge.
  • Some analysts have set lower price targets for the stock, with estimates as low as $215.00, suggesting potential volatility and uncertainty in the stock's future performance.
  • There are mixed ratings from analysts, with some holding a "Hold" rating, which may indicate a lack of consensus on the stock's attractiveness.
  • The healthcare sector can be subject to regulatory changes and market fluctuations, which may impact Cardinal Health, Inc.'s operations and profitability.

CAH Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $247.80, with a high forecast of $275.00 and a low forecast of $208.00.

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 3 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CAH shares.

According to analysts, Cardinal Health's stock has a predicted upside of 3.77% based on their 12-month stock forecasts.

Over the previous 90 days, Cardinal Health's stock had 2 downgrades and 1 upgrade by analysts.

Cardinal Health has been rated by research analysts at Bank of America, Citigroup, Evercore, JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, TD Cowen, Weiss Ratings, Wells Fargo & Company, William Blair, and Zacks Research in the past 90 days.

Analysts like Cardinal Health more than other "medical" companies. The consensus rating for Cardinal Health is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CAH compares to other companies.


This page (NYSE:CAH) was last updated on 7/3/2026 by MarketBeat.com Staff.
From Our Partners